Found 11 results
Author Title [ Type(Desc)] Year
Filters: Author is Sparenborg, S  [Clear All Filters]
Conference Paper
S. Sparenborg, Hu, L., Van Veldhuisen, P., Allen, C., and Tai, B., How Electronic Health Records (EHRs) Can Support Comparative Effectiveness Research (CER), in Annual Comparative Effectiveness Research Key Function Committee Meeting, Rockville, MD, 2012.
T. Winhusen, Lewis, D., Sharma, G., and Sparenborg, S., A Multi-Site, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence, in College on Problems of Drug Dependence Meeting, San Juan, Puerto Rico, 2014.
J. Annon, Hillhouse, M., Thomas, C., Mooney, L., Hasson, A., Walker, R., Chang, L., Sparenborg, S., Lindblad, R., VanVeldhuisen, P., and Ling, W., A New Study Methodology: ADAPT, The Short, Staged Trial, in 77th Annual Meeting of the College on Problems of Drug Dependence (CPDD), Phoenix, AZ, 2015.
U. Ghitza, Tai, B., McLellan, T., Lindblad, R., Gore-Langton, R., Sparenborg, S., and Saitz, R., NIDA Clinical Trials Network (CTN) Electronic Health Records Project: Public Opportunity for Input into Standardized Common Data Elements for Drug Abuse Treatment, in 8th Annual International Network on Brief Interventions for Alcohol Problems (INEBRIA), Boston, MA, 2011.
S. Sparenborg, Hu, L., J Potter, S., and Weiss, R., Pre-Existing Psychiatric Severity Did Not Affect Likelihood of Success in the Prescription Opiate Addiction Treatment Study (POATS), in College on Problems of Drug Dependence 74th Annual Meeting, Palm Springs, CA, 2012.
R. Lindblad, Saxon, A., Van Veldhuisen, P., Lu, L., Hu, L., Hasson, A., Thomas, C., Sparenborg, S., Mooney, L., and Ling, W., Safety of Combination Buprenorphine/Naloxone and Extended Release Naltrexone, in 2016 CPDD Scientific Meeting, Palm Springs, CA, 2016.
Journal Article
E. McClure, Sonne, S., Winhusen, T., Carroll, K., Ghitza, U., McRae-Clark, A., Matthews, A., Sharma, G., Van Veldhuisen, P., Vandrey, R., Levin, F., Weiss, R., Lindblad, R., Allen, C., Mooney, L., Haynes, L., Brigham, G., Sparenborg, S., Hasson, A., and Gray, K., Achieving Cannabis Cessation – Evaluating N-Acetylcysteine Treatment (ACCENT): Design and Implementation of a Multi-Site, Randomized Controlled Study in the National Institute on Drug Abuse Clinical Trials Network, Contemp Clin Trials, vol. 39, pp. 211-223, 2014.
W. Ling, Hillhouse, M. P., Saxon, A. J., Mooney, L. J., Thomas, C. M., Ang, A., Matthews, A. G., Hasson, A., Annon, J., Sparenborg, S., Liu, D. S., McCormack, J., Church, S., Swafford, W., Drexler, K., Schuman, C., Ross, S., Wiest, K., Korthuis, P., Lawson, W., Brigham, G. S., Knox, P. C., Dawes, M., and Rotrosen, J., Buprenorphine + Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study, Addiction, vol. 111, no. 6, pp. 1416-1427, 2016.
T. Winhusen, Brady, K. T., Stitzer, M., Woody, G., Lindblad, R., Kropp, F., Brigham, G., Liu, D., Sparenborg, S., Sharma, G., Van Veldhuisen, P., Adinoff, B., and Somoza, E., Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World, Contemp Clin Trials, vol. 33, pp. 993-1002, 2012.
B. Tai, Hu, L., Ghitza, U. E., Sparenborg, S., Van Veldhuisen, P., and Lindblad, R., Patient Registries for Substance Use Disorders, Subst Abuse Rehabil, vol. 5, pp. 81-86, 2014.
L. J. Mooney, Hillhouse, M. P., Thomas, C., Ang, A., Sharma, G., Terry, G., Chang, L., Walker, R., Trivedi, M., Croteau, D., Sparenborg, S., and Ling, W., Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder, J Addict Med, vol. 10, no. 4, pp. 236-243, 2016.